Broadcom
AVGO
Alibaba
BABA
NVIDIA
NVDA
Tesla
TSLA
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
JANX Janux Therapeutics
- 40.720
- +0.110+0.27%
Close Jan 17 16:00 ET
- 40.720
- 0.0000.00%
Post 20:01 ET
2.39BMarket Cap-34.80P/E (TTM)
42.380High40.510Low802.31KVolume41.090Open40.610Pre Close33.09MTurnover1.81%Turnover RatioLossP/E (Static)58.63MShares71.71052wk High3.64P/B1.80BFloat Cap7.79052wk Low--Dividend TTM44.22MShs Float71.710Historical High--Div YieldTTM4.61%Amplitude5.650Historical Low41.243Avg Price1Lot Size
Janux Therapeutics News
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McIver Zachariah
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Winter Charles M.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Robinson Byron
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DiRaimondo Thomas
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dobek Maria
Janux Therapeutics | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Officer Winter Charles M.
Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer McIver Zachariah
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meyer Andrew Hollman
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meyer Andrew Hollman
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Campbell, Ph.D.(4.8%)
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(2.0%),Citadel Advisors LLC(1.9%), etc.
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)
Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(4.1%),Tighe Reardon(3.0%), etc.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gujrathi Sheila
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.